(Updated - November 7, 2016 4:09 PM EST)Canadian pharmaceutical conglomerate Valeant Pharmaceuticals International, Inc., (NYSE: VRX) parent of Bausch + ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Litigation Mergers and Acquisitions Short Sales Spinoffs

Valeant Pharma (VRX) Sinks 27% in Pre-Open Trade, Falling Below $14November 8, 2016 8:56 AM